Since they debuted, injectable GLP-1 drugs like Ozempic have been in high demand. It’s an appealing prospect—especially since these drugs are offered at a fraction of the price of their name-brand counterparts and are often shipped overnight after a prospective patient fills out a quick online questionnaire. “As a pharmacist, I can appreciate the excitement in the rise in oral …
Ozempic and Wegovy have become two of the fastest-selling drugs ever, irrevocably changing the obesity treatment landscape - but there have been a couple of catches. Novo Nordisk, the Danish company behind Wegovy and Ozempic, as well as Indiana-based Eli Lilly and New York-based Pfizer, are vying to become the first company to introduce a highly effective, safe, and extremely …
